vs

Side-by-side financial comparison of LifeStance Health Group, Inc. (LFST) and Sylvamo Corp (SLVM). Click either name above to swap in a different company.

Sylvamo Corp is the larger business by last-quarter revenue ($755.0M vs $382.2M, roughly 2.0× LifeStance Health Group, Inc.). LifeStance Health Group, Inc. runs the higher net margin — 3.1% vs -0.4%, a 3.5% gap on every dollar of revenue. On growth, LifeStance Health Group, Inc. posted the faster year-over-year revenue change (17.4% vs -8.0%). LifeStance Health Group, Inc. produced more free cash flow last quarter ($46.6M vs $-59.0M). Over the past eight quarters, LifeStance Health Group, Inc.'s revenue compounded faster (12.8% CAGR vs -10.0%).

Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.

Sylvamo Corp is a leading global manufacturer of sustainable paper and pulp products. Its core offerings include uncoated printing paper, packaging paper, and market pulp, serving office supplies, publishing, commercial printing, and packaging segments across North America, Europe, and Latin America.

LFST vs SLVM — Head-to-Head

Bigger by revenue
SLVM
SLVM
2.0× larger
SLVM
$755.0M
$382.2M
LFST
Growing faster (revenue YoY)
LFST
LFST
+25.5% gap
LFST
17.4%
-8.0%
SLVM
Higher net margin
LFST
LFST
3.5% more per $
LFST
3.1%
-0.4%
SLVM
More free cash flow
LFST
LFST
$105.6M more FCF
LFST
$46.6M
$-59.0M
SLVM
Faster 2-yr revenue CAGR
LFST
LFST
Annualised
LFST
12.8%
-10.0%
SLVM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
LFST
LFST
SLVM
SLVM
Revenue
$382.2M
$755.0M
Net Profit
$11.7M
$-3.0M
Gross Margin
Operating Margin
4.7%
Net Margin
3.1%
-0.4%
Revenue YoY
17.4%
-8.0%
Net Profit YoY
264.1%
EPS (diluted)
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LFST
LFST
SLVM
SLVM
Q1 26
$755.0M
Q4 25
$382.2M
$890.0M
Q3 25
$363.8M
$846.0M
Q2 25
$345.3M
$794.0M
Q1 25
$333.0M
$821.0M
Q4 24
$325.5M
$970.0M
Q3 24
$312.7M
$965.0M
Q2 24
$312.3M
$933.0M
Net Profit
LFST
LFST
SLVM
SLVM
Q1 26
$-3.0M
Q4 25
$11.7M
$33.0M
Q3 25
$1.1M
$57.0M
Q2 25
$-3.8M
$15.0M
Q1 25
$709.0K
$27.0M
Q4 24
$-7.1M
$81.0M
Q3 24
$-6.0M
$95.0M
Q2 24
$-23.3M
$83.0M
Operating Margin
LFST
LFST
SLVM
SLVM
Q1 26
Q4 25
4.7%
8.9%
Q3 25
2.0%
11.6%
Q2 25
-0.9%
3.8%
Q1 25
0.5%
5.4%
Q4 24
0.3%
11.2%
Q3 24
0.0%
15.5%
Q2 24
-5.1%
13.1%
Net Margin
LFST
LFST
SLVM
SLVM
Q1 26
-0.4%
Q4 25
3.1%
3.7%
Q3 25
0.3%
6.7%
Q2 25
-1.1%
1.9%
Q1 25
0.2%
3.3%
Q4 24
-2.2%
8.4%
Q3 24
-1.9%
9.8%
Q2 24
-7.5%
8.9%
EPS (diluted)
LFST
LFST
SLVM
SLVM
Q1 26
$-0.08
Q4 25
$0.81
Q3 25
$1.41
Q2 25
$0.37
Q1 25
$0.65
Q4 24
$1.91
Q3 24
$2.27
Q2 24
$1.98

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LFST
LFST
SLVM
SLVM
Cash + ST InvestmentsLiquidity on hand
$248.6M
Total DebtLower is stronger
$282.8M
$766.0M
Stockholders' EquityBook value
$1.5B
$979.0M
Total Assets
$2.2B
$2.8B
Debt / EquityLower = less leverage
0.19×
0.78×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LFST
LFST
SLVM
SLVM
Q1 26
Q4 25
$248.6M
$198.0M
Q3 25
$203.9M
$146.0M
Q2 25
$188.9M
$183.0M
Q1 25
$134.3M
$220.0M
Q4 24
$154.6M
$309.0M
Q3 24
$102.6M
$414.0M
Q2 24
$87.0M
$213.0M
Total Debt
LFST
LFST
SLVM
SLVM
Q1 26
$766.0M
Q4 25
$282.8M
$763.0M
Q3 25
$284.6M
$778.0M
Q2 25
$286.4M
$767.0M
Q1 25
$288.2M
$794.0M
Q4 24
$290.0M
$782.0M
Q3 24
$287.3M
$883.0M
Q2 24
$288.0M
$894.0M
Stockholders' Equity
LFST
LFST
SLVM
SLVM
Q1 26
$979.0M
Q4 25
$1.5B
$966.0M
Q3 25
$1.5B
$977.0M
Q2 25
$1.5B
$959.0M
Q1 25
$1.5B
$908.0M
Q4 24
$1.4B
$847.0M
Q3 24
$1.4B
$937.0M
Q2 24
$1.4B
$830.0M
Total Assets
LFST
LFST
SLVM
SLVM
Q1 26
$2.8B
Q4 25
$2.2B
$2.8B
Q3 25
$2.1B
$2.7B
Q2 25
$2.1B
$2.7B
Q1 25
$2.1B
$2.6B
Q4 24
$2.1B
$2.6B
Q3 24
$2.1B
$2.9B
Q2 24
$2.1B
$2.7B
Debt / Equity
LFST
LFST
SLVM
SLVM
Q1 26
0.78×
Q4 25
0.19×
0.79×
Q3 25
0.19×
0.80×
Q2 25
0.19×
0.80×
Q1 25
0.20×
0.87×
Q4 24
0.20×
0.92×
Q3 24
0.20×
0.94×
Q2 24
0.20×
1.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LFST
LFST
SLVM
SLVM
Operating Cash FlowLast quarter
$57.6M
Free Cash FlowOCF − Capex
$46.6M
$-59.0M
FCF MarginFCF / Revenue
12.2%
-7.8%
Capex IntensityCapex / Revenue
2.9%
Cash ConversionOCF / Net Profit
4.93×
TTM Free Cash FlowTrailing 4 quarters
$110.0M
$10.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LFST
LFST
SLVM
SLVM
Q1 26
Q4 25
$57.6M
$94.0M
Q3 25
$27.3M
$87.0M
Q2 25
$64.4M
$64.0M
Q1 25
$-3.1M
$23.0M
Q4 24
$62.3M
$164.0M
Q3 24
$22.7M
$163.0M
Q2 24
$44.1M
$115.0M
Free Cash Flow
LFST
LFST
SLVM
SLVM
Q1 26
$-59.0M
Q4 25
$46.6M
$38.0M
Q3 25
$17.0M
$33.0M
Q2 25
$56.6M
$-2.0M
Q1 25
$-10.3M
$-25.0M
Q4 24
$56.0M
$100.0M
Q3 24
$17.7M
$119.0M
Q2 24
$39.0M
$62.0M
FCF Margin
LFST
LFST
SLVM
SLVM
Q1 26
-7.8%
Q4 25
12.2%
4.3%
Q3 25
4.7%
3.9%
Q2 25
16.4%
-0.3%
Q1 25
-3.1%
-3.0%
Q4 24
17.2%
10.3%
Q3 24
5.7%
12.3%
Q2 24
12.5%
6.6%
Capex Intensity
LFST
LFST
SLVM
SLVM
Q1 26
Q4 25
2.9%
6.3%
Q3 25
2.8%
6.4%
Q2 25
2.2%
8.3%
Q1 25
2.2%
5.8%
Q4 24
1.9%
6.6%
Q3 24
1.6%
4.6%
Q2 24
1.6%
5.7%
Cash Conversion
LFST
LFST
SLVM
SLVM
Q1 26
Q4 25
4.93×
2.85×
Q3 25
25.34×
1.53×
Q2 25
4.27×
Q1 25
-4.36×
0.85×
Q4 24
2.02×
Q3 24
1.72×
Q2 24
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LFST
LFST

Segment breakdown not available.

SLVM
SLVM

North America$390.0M52%
Europe$190.0M25%
Latin America$187.0M25%

Related Comparisons